NCT04350255 A Register Based Prospective Study During Implementation of a New Cup
| NCT ID | NCT04350255 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sahlgrenska University Hospital |
| Condition | Prospective |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2020-08-01 |
| Primary Completion | 2024-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2020-08-01 with a primary completion date of 2024-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In a prospective register-based study, we aim to evaluate the implant survival, clinical outcomes and X-ray findings by following a cohort of patients operated with the Trident II cup.
Eligibility Criteria
Inclusion Criteria: * Primary hip replacement * Eligible for uncemented fixation of the acetabular component * Suitable for one of the stem designs from Stryker Orthopaedics * Accepts follow-up according to the study protocol Exclusion Criteria: * Difficulties to understand written information due to language problems or other reasons * Use of augments needed * Acute hip fracture * Tumor in the hip joint
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04350255 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 75 Years, studying Prospective. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04350255 currently recruiting?
Yes, NCT04350255 is actively recruiting participants. Contact the research team at maziar.mohaddes@gmail.com for enrollment information.
Where is the NCT04350255 trial being conducted?
This trial is being conducted at Mölndal, Sweden.
Who is sponsoring the NCT04350255 clinical trial?
NCT04350255 is sponsored by Sahlgrenska University Hospital. The trial plans to enroll 500 participants.